Clinical Trial
[The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer]
[Article in
Russian]
Affiliations
- PMID: 9807203
Item in Clipboard
Clinical Trial
[The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer]
[Article in
Russian]
Vopr Onkol.
1998.
Abstract
The role of adjuvant therapy in breast-conserving treatment was studied in 360 cancer patients (reproductive, aged < or = 55 yrs, and postmenopausal, aged > 55 yrs) with T1-2N0M0 tumors under 2.5 cm (1985-1996). Mortality rates fell by 17% in postmenopausal patients who received adjuvant therapy (tamoxifen) and by 34%--in the reproductive group after polychemotherapy (CMF) and 36%--after hormonal therapy (tamoxifen).
Similar articles
-
[Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].Vopr Onkol. 1999;45(5):516-9. Vopr Onkol. 1999. PMID: 10629708 Clinical Trial. Russian.
-
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.J Clin Oncol. 2005 Nov 1;23(31):7842-8. doi: 10.1200/JCO.2005.01.3433. J Clin Oncol. 2005. PMID: 16258087 Clinical Trial.
-
Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.Acta Oncol. 2009;48(4):504-13. doi: 10.1080/02841860902718754. Acta Oncol. 2009. PMID: 19235568
-
Adjuvant treatment of breast cancer.R I Med. 1995 Sep;78(9):250-3. R I Med. 1995. PMID: 7579720 Review. No abstract available.
-
Endocrine therapy for early breast cancer.Expert Rev Anticancer Ther. 2004 Oct;4(5):877-88. doi: 10.1586/14737140.4.5.877. Expert Rev Anticancer Ther. 2004. PMID: 15485321 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical